MetaCap

EUDA Health (EUDA) vs Starling Oncology (STLN)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Starling Oncology (STLN) has outperformed EUDA Health (EUDA) over the past year, losing 4.2% versus a loss of 71.8%. Starling Oncology is the larger company by market cap ($306.0 million vs $47.8 million), about 6.4 times the size, while EUDA Health is growing revenue faster (+70.0% vs +27.8%). Starling Oncology converts more of its revenue into profit, with a net margin of -12.1% versus -40.7%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

EUDA-71.80%STLN-4.15%
+136%+17%-102%
Nov 21, 20251 yearNov 20, 2026
EUDA-91.75%STLN-52.98%
+72%-17%-106%
Dec 13, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

EUDA versus STLN key metrics
MetricEUDASTLN
Share price$15.96$3.00
Market cap$47.79M$305.97M
1-day change-7.69%-5.66%
YTD return-65.45%-15.73%
1-year return-71.80%-4.15%
5-year return—-55.29%
Forward P/E9.97—
EPS (TTM)$-1.18$-0.28
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$6.82M$502.73M
Revenue growth (YoY)+70.04%+27.79%
Net income (latest FY)$-2.77M$-60.61M
Gross margin43.88%—
Operating margin-36.33%-7.18%
Net margin-40.65%-12.06%
52-week high$68.00$7.13
52-week low$5.26$2.32
Distance from 52-week high-76.53%-57.92%
Analyst consensusnonestrong_buy
Avg. price target upside+244.61%+208.33%
Average volume37.77K2.55M
Shares outstanding2.99M101.99M
Employees123641
SectorHealth CareHealth Care
IndustryMedical/Nursing ServicesMedical/Nursing Services

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Starling Oncology is about 6.4 times larger than EUDA Health by market value ($305.97M vs $47.79M).
  • STLN has outperformed EUDA by 67.6 percentage points over the past year.
  • Starling Oncology is more profitable, keeping -12.1 cents of every revenue dollar as net income versus -40.7 cents for EUDA Health.
  • EUDA Health grew revenue faster in its latest fiscal year (+70.04% vs +27.79%).

About EUDA Health

EUDA stock →

EUDA Health Holdings Limited engages in the provision of non-invasive healthcare services primarily in Singapore, Malaysia, and China. It offers bioenergy cabin therapy packages; stem cell therapy services through third-party treatment centers; and holistic wellness consumer products and services.

Health Care · Medical/Nursing Services · 123 employees

About Starling Oncology

STLN stock →

Starling Oncology, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other.

Health Care · Medical/Nursing Services · 641 employees

EUDA vs STLN FAQ

Which is bigger, EUDA Health or Starling Oncology?

Starling Oncology (STLN) is larger, with a market capitalization of $305.97M compared with $47.79M for EUDA Health (EUDA).

Which stock has performed better over the past year, EUDA or STLN?

STLN returned -4.15% over the past 12 months, compared with -71.80% for EUDA (price return, excluding dividends). Past performance does not predict future results.

Are EUDA Health and Starling Oncology in the same industry?

Yes. Both are classified in the Medical/Nursing Services industry within the Health Care sector.

More comparisons